| Serial Number | 88344838 |
| Word Mark | ADAPTDX |
| Filing Date | Monday, March 18, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 25, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 28, 2020 |
| Goods and Services | Immunosequencing-based assay kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detection of cancer, autoimmune disease and infection; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection; the aforementioned goods not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment |
| Goods and Services | Medical laboratory services; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment |
| Goods and Services | Providing medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; medical services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment |
| Pseudo Mark | ADAPTED |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 3, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 5, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 3, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Adaptive Biotechnologies Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98102 |
| Party Name | Adaptive Biotechnologies Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98102 |
| Event Date | Event Description |
| Monday, October 25, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, October 25, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, March 24, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 22, 2021 | EXTENSION 2 GRANTED |
| Monday, March 22, 2021 | EXTENSION 2 FILED |
| Monday, March 22, 2021 | TEAS EXTENSION RECEIVED |
| Thursday, September 17, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 15, 2020 | EXTENSION 1 GRANTED |
| Tuesday, September 15, 2020 | EXTENSION 1 FILED |
| Tuesday, September 15, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, March 24, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 28, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 28, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 8, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, December 23, 2019 | ASSIGNED TO LIE |
| Friday, December 20, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 3, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 2, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 2, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 4, 2019 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, June 4, 2019 | PRIORITY ACTION E-MAILED |
| Tuesday, June 4, 2019 | PRIORITY ACTION WRITTEN |
| Tuesday, May 28, 2019 | ASSIGNED TO EXAMINER |
| Friday, April 5, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, March 21, 2019 | NEW APPLICATION ENTERED IN TRAM |